Analyst Ratings for DuPont de Nemours
DuPont de Nemours (NYSE:DD) has observed the following analyst ratings within the last quarter:
Where DuPont de Nemours Stands With Analysts
Over the past 3 months, 7 analysts have published their opinion on DuPont de Nemours (NYSE:DD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Deutsche Bank Maintains Buy on DuPont de Nemours, Lowers Price Target to $90
Deutsche Bank analyst David Begleiter maintains DuPont de Nemours (NYSE:DD) with a Buy and lowers the price target from $100 to $90.
Vegan Stocks Bolstered By Rising Interest In Textured Vegetable Protein Options
Initially invented and patented in the 1960s to extend ground meat as a means of reducing costs without reducing nutritional value, Textured Vegetable Proteins (TVPs) have recently received a huge boost from growing demand in plant-based protein options for vegetarians, vegans, and flexitarians,” reported FN Media Group in a
Keybanc Maintains Overweight on DuPont de Nemours, Raises Price Target to $99
Keybanc analyst Aleksey Yefremov maintains DuPont de Nemours (NYSE:DD) with a Overweight and raises the price target from $95 to $99.
Celanese Reports Purchase Of Majority Of DuPont’s Mobility & Materials Business For $11B In Cash
Establishes Celanese as the Preeminent Global Specialty Materials Company
Acquisition expected to generate approximately $450 million of synergies and be immediately accretive to adjusted EPS
Acquisition
6 Companies That Recently Announced Large Buybacks
There are several ways that a company can return wealth to its shareholders. Price appreciation and dividends are the two most common ways, but there are other ways a company can introduce returns to buyers. One method that is less common, or overlooked, is share buybacks.
Analyst Ratings For DuPont de Nemours
Analysts have provided the following ratings for DuPont de Nemours (NYSE:DD) within the last quarter:
DuPont de Nemours Q4 EPS $1.08 Misses $1.13 Estimate, Sales $4.27B Beat $4.20B Estimate
DuPont de Nemours (NYSE:DD) reported quarterly earnings of $1.08 per share which missed the analyst consensus estimate of $1.13 by 4.42 percent. This is a 13.68 percent increase over earnings of $0.95 per share from the
Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell
• Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.